课题基金 / 基金详情

ACTIVIN RECEPTORS AND SMAD2 IN MAMMALIAN GASTRULATION

ACTIVIN RECEPTORS AND SMAD2 IN MAMMALIAN GASTRULATION
哺乳动物原肠胚形成中的激活素受体和 SMAD2
批准号:
2842803
负责人:
EN LI
金额:
$25.88万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-06-01 至 2004-03-31

项目摘要

项目成果

EN LI的其他基金

相似基金

相关文献

中文摘要
翻译
转化生长因子-β超家族分子在多种发育过程中发挥着重要作用。我们的长期目标是了解转化生长因子-β家族因子调节形态发生的信号机制。中胚层诱导和原肠形成是导致体轴建立的关键事件。转化生长因子-β家族的成员,如激活素、VG-1、结节和骨形态发生蛋白,是脊椎动物早期发育过程中强有力的中胚层诱导因子和功能。激活素或BMP激活的信号级联和发育程序在非洲爪哇和鸡的早期胚胎中已经得到了广泛的研究。然而,目前尚不清楚这些信号通路在哺乳动物中是否保守。遗传学研究已经证明,结节和BMP4,而不是合子激活素,对于小鼠的早期发育是必不可少的。为了研究激活素I型和II型受体及其下游信号调节因子Smad2在哺乳动物发育中的作用,我们通过靶向干扰相应的基因产生了突变小鼠。对突变小鼠的遗传学和胚胎学研究提供了直接证据,表明激活素受体和Smad2对于中胚层形成和原肠形成是必不可少的。为了进一步分析激活素受体和Smad2介导的信号通路在调节细胞生长和分化、原始条纹形成和原肠形成中的作用,提出了以下具体目标:(1)了解激活素受体和Smad2如何调控卵筒形成和原肠形成过程中的胚胎生长、胚层组织和细胞命运决定。(2)探讨激活素受体和Smad2对原始条纹形成和中胚层图案化的调节作用。3)探讨Node、BMP4和Chordin在原始条纹形成中的作用及其信号转导途径。本项目将采用胚胎干细胞显微注射嵌合体(或嵌合体)分析、原位杂交、LacZ标记突变的ES细胞谱系分析、ES细胞介导的基因传递等方法。这些目标一旦实现,将有助于更好地理解控制哺乳动物早期发育的信号机制。获得的早期胚胎发育知识将有助于理解器官发生等后期发育过程,并将对理解人类各种形式出生缺陷的遗传基础具有重要意义。
英文摘要
The transforming growth factor-beta (TGF-beta) superfamily molecules play critical roles in a diverse range of developmental processes. Our long term goal is to understand the signaling mechanism by which TGF-beta family factors regulate morphogenesis. Mesoderm induction and gastrulation are key events that lead to the establishment of body axes. Members of the TGF-beta family such as activins, Vg-1, nodal, and BMPs are potent mesoderm inducing factors and function during early development in vertebrate animals. The signaling cascade and the developmental program activated by activin or BMP has been extensively studied in Xenopus and chick early embryos. However, it remains unclear whether these signaling pathways are conserved in mammals. Genetic studies have demonstrated that nodal and BMP4, but not zygotic activins, are essential for early mouse development. To investigate the function of activin type I and type II receptors and a downstream signal mediator Smad2 in mammalian development, mutant mice have been generated by targeted disruption of the corresponding genes in mice. Genetic and embryological studies of the mutant mice have provided direct evidence that activin receptors and Smad2 are essential for mesoderm formation and gastrulation. To further analyze the function of activin receptor- and Smad2- mediated signaling pathways in the regulation of cell growth and differentiation, primitive streak formation and gastrulation, the following specific aims are proposed: (1) To understand how activin receptors and Smad2 regulate embryo growth, germ layer organization, and cell fate determination during egg cylinder formation and gastrulation. (2) To investigate how activin receptors and Smad2 regulate primitive streak formation and mesoderm patterning. 3) To investigate the function of nodal, BMP4, and chordin and their signaling pathways in primitive streak formation. Methods such as chimera (or mosaic) analysis through microinjection of blastocysts or aggregation of tetraploid embryos with ES cells, in situ hybridization, lineage analysis with lacZ-marked mutant ES cells, and ES cell-mediated gene delivery will be applied in this project. These aims, once accomplished, will lead to a better understanding of the signaling mechanism that controls early mammalian development. The knowledge acquired regarding early embryonic development will be useful for understanding later developmental processes such as organogenesis and will have important implications towards understanding the genetic basis of various forms of birth defects in human.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DE NOVO METHYLTRANSFERASES AND CANCER
  • 批准号:
    6377347
  • 项目类别:
  • 资助金额:
    $22.36万
  • 财政年份:
    1999
  • 负责人:
    EN LI
  • 依托单位:
ACTIVIN RECEPTORS AND SMAD2 IN MAMMALIAN GASTRULATION
  • 批准号:
    6521019
  • 项目类别:
  • 资助金额:
    $26.56万
  • 财政年份:
    1999
  • 负责人:
    EN LI
  • 依托单位:
ACTIVIN RECEPTORS AND SMAD2 IN MAMMALIAN GASTRULATION
  • 批准号:
    6181876
  • 项目类别:
  • 资助金额:
    $25.03万
  • 财政年份:
    1999
  • 负责人:
    EN LI
  • 依托单位:
DE NOVO METHYLTRANSFERASES AND CANCER
  • 批准号:
    6173622
  • 项目类别:
  • 资助金额:
    $22.69万
  • 财政年份:
    1999
  • 负责人:
    EN LI
  • 依托单位:
海外基金